INMED PHARMACEUTICALS INC. Inventory Adjustments
INMED PHARMACEUTICALS INC. (INM) had Inventory Adjustments of -$576.77 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Notes › Inventory › Inventory, Net of Allowances, Customer Advances and Progress Billings
us-gaap:InventoryAdjustments · last filed 2023-05-15
- 2023-03-31: Inventory Adjustments -$576.77K.
- 2022-12-31: Inventory Adjustments -$576.77K.
| Period end | Inventory Adjustments |
|---|---|
| 2023-03-31 | -$576.77K 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$576.77K 10-Q · filed 2023-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |